Changes detected by mRNA analysis, such as NRP1 down regulation in HS-578 T (BC), were not translated into protein changes, suggesting alternative regulatory mechanisms, which may be a result of translational variations or post translational modifications along the secretory pathway. This evidence concerns the gene NRP1 and breast cancer.